{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:08:29Z","timestamp":1791590909039,"version":"4.3.4"},"reference-count":39,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Shanghai Sailing Program","award":["22YF1440000"],"award-info":[{"award-number":["22YF1440000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070865"],"award-info":[{"award-number":["82070865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201396"],"award-info":[{"award-number":["82201396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270931"],"award-info":[{"award-number":["82270931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301005"],"award-info":[{"award-number":["82301005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hyperglycemia (HG) is a well-established risk factor for secondary osteoporosis, primarily due to suppressed osteoblast activity. While gut microbiota (GM) dysbiosis has been implicated in various diseases, its role in HG-induced osteoporosis remains poorly understood. Here, we demonstrate that HG mice develop low-turnover osteoporosis accompanied by reduced GM diversity. Fecal microbiota transplantation (FMT) from HG mice (GMHG-FMT) induced osteoporosis in recipient mice, independent of blood glucose levels. A depletion of Bifidobacterium pseudolongum was associated with bone loss, whereas supplementation with either microbiota of normoglycemic mice or B. pseudolongum alleviated osteoporosis in HG mice. Both HG and GMHG-FMT recipient mice exhibited elevated serum interleukin-17A (IL-17A) levels, and anti\u2013IL-17A antibody treatment mitigated osteoporosis in the GMHG-FMT model. Furthermore, decanoic acid levels were elevated in the feces of HG mice and the serum of GMHG-FMT recipients. Decanoic acid promoted the differentiation of naive CD4+ T\u00a0cells into T helper17 cells, leading to increased IL-17A production. These findings reveal a microbiome dysbiosis-driven decanoic acid\/IL-17A axis in HG-induced osteoporosis and highlight the therapeutic potential of microbiome-associated targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>This study investigated the role of gut microbiota dysbiosis in hyperglycemia-induced osteoporosis, a condition with unclear mechanisms. We explored whether gut microbiota dysbiosis drives bone loss in hyperglycemia and identified key microbial and molecular pathways. Hyperglycemic mice showed disturbed gut microbiota symbiosis, decreased Bifidobacterium pseudolongum, and elevated decanoic acid, which promoted T helper 17 differentiation and interleukin-17A (IL-17A) production, leading to osteoporosis. Fecal microbiota transplantation from control mice, B. pseudolongum supplementation, and IL-17A blockade alleviated bone loss, highlighting both B. pseudolongum supplementation and IL-17A inhibition as potential therapeutic strategies for hyperglycemia-induced osteoporosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0471","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:35:31Z","timestamp":1761586531000},"page":"154-165","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":4,"title":["Gut Microbiota\u2013Decanoic Acid\u2013Interleukin-17A Axis Orchestrates Hyperglycemia-Induced Osteoporosis in Male Mice"],"prefix":"10.2337","volume":"75","author":[{"given":"Tao","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"},{"name":"Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine 3 , Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changkun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcan","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kecheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 4 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0179-1751","authenticated-orcid":false,"given":"Jianmin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-1648","authenticated-orcid":false,"given":"Yanyun","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5921-480X","authenticated-orcid":false,"given":"Bei","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 1 , Shanghai, China"},{"name":"Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the Peoples Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 2 , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2026061115275702000_B1","doi-asserted-by":"crossref","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","article-title":"Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"2026061115275702000_B2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2026061115275702000_B3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"2026061115275702000_B4","doi-asserted-by":"crossref","first-page":"e70091","DOI":"10.1111\/1753-0407.70091","article-title":"New evidence, creative insights, and strategic solutions: advancing the understanding and practice of diabetes osteoporosis","volume":"17","author":"Tao","year":"2025","journal-title":"J Diabetes"},{"key":"2026061115275702000_B5","doi-asserted-by":"crossref","first-page":"e70068","DOI":"10.1111\/1753-0407.70068","article-title":"Gut microbiota and their metabolites: the hidden driver of diabetic nephropathy? Unveiling gut microbe\u2019s role in DN","volume":"17","author":"Liu","year":"2025","journal-title":"J Diabetes"},{"key":"2026061115275702000_B6","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI86062","article-title":"Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics","volume":"126","author":"Li","year":"2016","journal-title":"J Clin Invest"},{"key":"2026061115275702000_B7","doi-asserted-by":"crossref","first-page":"eabg8335","DOI":"10.1126\/sciadv.abg8335","article-title":"Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis","volume":"8","author":"Chen","year":"2022","journal-title":"Sci Adv"},{"key":"2026061115275702000_B8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrd3669","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2026061115275702000_B9","first-page":"0363","article-title":"Remodeling intestinal microbiota alleviates severe combined hyperlipidemia-induced nonalcoholic steatohepatitis and atherosclerosis in LDLR\u2212\/\u2212 hamsters","volume":"7","author":"Miao","year":"2024","journal-title":"Research (Wash D C)"},{"key":"2026061115275702000_B10","doi-asserted-by":"crossref","first-page":"2108280","DOI":"10.1080\/19490976.2022.2108280","article-title":"Fatty acids produced by the gut microbiota dampen host inflammatory responses by modulating intestinal SUMOylation","volume":"14","author":"Ezzine","year":"2022","journal-title":"Gut Microbes"},{"key":"2026061115275702000_B11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2021.03.002","article-title":"Role of medium-chain fatty acids in healthy metabolism: a clinical perspective","volume":"32","author":"Huang","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"2026061115275702000_B12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12986-019-0359-2","article-title":"Caprylic acid suppresses inflammation via TLR4\/NF-\u03baB signaling and improves atherosclerosis in apoE-deficient mice","volume":"16","author":"Zhang","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"2026061115275702000_B13","doi-asserted-by":"crossref","first-page":"625034","DOI":"10.3389\/fimmu.2020.625034","article-title":"Interleukin-17A interweaves the skeletal and immune systems","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"2026061115275702000_B14","doi-asserted-by":"crossref","first-page":"e13593","DOI":"10.1111\/1753-0407.13593","article-title":"Probiotic treatment with viable \u03b1-galactosylceramide-producing Bacteroides fragilis reduces diabetes incidence in female nonobese diabetic mice","volume":"16","author":"Hansen","year":"2024","journal-title":"J Diabetes"},{"key":"2026061115275702000_B15","doi-asserted-by":"crossref","first-page":"e13485","DOI":"10.1111\/1753-0407.13485","article-title":"Washed microbiota transplantation reduces glycemic variability in unstable diabetes","volume":"16","author":"Li","year":"2024","journal-title":"J Diabetes"},{"key":"2026061115275702000_B16","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr Protoc"},{"key":"2026061115275702000_B17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40168-020-00988-6","article-title":"Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Hou","year":"2021","journal-title":"Microbiome"},{"key":"2026061115275702000_B18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2020.08.012","article-title":"Warmth prevents bone loss through the gut microbiota","volume":"32","author":"Chevalier","year":"2020","journal-title":"Cell Metab"},{"key":"2026061115275702000_B19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"2026061115275702000_B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"2026061115275702000_B21","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat Commun"},{"key":"2026061115275702000_B22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","article-title":"Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis","volume":"11","author":"Lyu","year":"2023","journal-title":"Bone Res"},{"key":"2026061115275702000_B23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/03008207.2016.1171858","article-title":"Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice","volume":"57","author":"Peng","year":"2016","journal-title":"Connect Tissue Res"},{"key":"2026061115275702000_B24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","article-title":"IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab"},{"key":"2026061115275702000_B25","doi-asserted-by":"crossref","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Ulu\u00e7kan","year":"2016","journal-title":"Sci Transl Med"},{"key":"2026061115275702000_B26","first-page":"17","article-title":"Role of IL-17A signalling in psoriasis and associated bone loss","volume":"34","author":"Ulu\u00e7kan","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2026061115275702000_B27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2026061115275702000_B28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S2222-1808(14)60598-3","article-title":"IL-17A plays an important role in induction of type 2 diabetes and its complications","volume":"4","author":"Yousefidaredor","year":"2014","journal-title":"Asian Pac J Trop Dis"},{"key":"2026061115275702000_B29","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-019-38811-4","article-title":"Interleukin 17A promotes diabetic kidney injury","volume":"9","author":"Ma","year":"2019","journal-title":"Sci Rep"},{"key":"2026061115275702000_B30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","article-title":"Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy","volume":"95","author":"Lavoz","year":"2019","journal-title":"Kidney Int"},{"key":"2026061115275702000_B31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/clinem\/dgae483","article-title":"Serum medium-chain fatty acids and the risk of incident diabetes: findings from the 4C Study","volume":"110","author":"Jia","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061115275702000_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2020.1854675","article-title":"The role of short-chain fatty acids in immunity, inflammation and metabolism","volume":"62","author":"Yao","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2026061115275702000_B33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"2026061115275702000_B34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"2026061115275702000_B35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J Hepatol"},{"key":"2026061115275702000_B36","doi-asserted-by":"crossref","first-page":"2073132","DOI":"10.1080\/19490976.2022.2073132","article-title":"Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection","volume":"14","author":"Kim","year":"2022","journal-title":"Gut Microbes"},{"key":"2026061115275702000_B37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1017\/S0007114509992145","article-title":"Role of intestinal Bifidobacterium pseudolongum in dietary fructo-oligosaccharide inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice","volume":"103","author":"Sasajima","year":"2010","journal-title":"Br J Nutr"},{"key":"2026061115275702000_B38","doi-asserted-by":"crossref","first-page":"105602","DOI":"10.1016\/j.jsbmb.2020.105602","article-title":"Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food","volume":"198","author":"Bo","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026061115275702000_B39","doi-asserted-by":"crossref","first-page":"e0252422","DOI":"10.1128\/spectrum.02524-22","article-title":"Clostridium butyricum and Bifidobacterium pseudolongum attenuate the development of cardiac fibrosis in mice","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/1\/154\/845067\/db250471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/1\/154\/845067\/db250471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:28:09Z","timestamp":1781206089000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/1\/154\/163690\/Gut-Microbiota-Decanoic-Acid-Interleukin-17A-Axis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0471","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}